On Monday, March 18, Japanese tech giant Fujitsu unveiled a smartphone can take the pulse of the users just by looking at their faces; and said that it has plans underway to put the inventive device to practical use within one year.
The smartphone's ability to take the pulse of the users by glancing at the face is based on the fact that it can measure the variations in the brightness which the flow of blood brings to the faces of the users.
With researchers having revealed that the innumerable small blood vessels which run through the face enable the monitoring of green light-absorbing haemoglobin, the Fujitsu smartphone works in such a way that the user's pulse is taken when a camera is pointed at his/her face for as little as five seconds. The technology used in the smartphone automatically filters out the impact of head movements or changes caused when the users stand up quickly.
According to Fujitsu, once the smartphone has been put to practical use, it will enable people at work or at home to keep track of their health as well as collect data for analysis, without having to wear special devices.
The company said in a press release: "Even at a busy workplace, or any time a person is sitting in front of a PC, whether for teleconferencing or writing e-mails, their pulse can be measured during brief moments of quiet."
According to recent rumors as well as insider tips, Microsoft will likely unveil a ‘Slim’ model of its Xbox One game console at the 2016 Electronic Entertainment Expo (E3) in Los Angeles.
The new Xbox One ‘Slim’ model will reportedly be...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle...
Paying in cash is any day better than taking a loan from a loan shark. In good old days people used a wad of cash to pay everything starting from furniture to grocery, if they did not have enough, they would wait for something cheaper or for the...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
In an apparent attempt to enhance the visual experience for Google search users carrying out...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
Chinese device manufacturer Lenovo officially unveiled...
Motorola’s newest flagship devices -- the Moto Z and the...
In an announcement made on Thursday, electric vehicle...
The Verge has revealed in a Wednesday report, citing a...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).